Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 21;16(1):75.
doi: 10.1186/s13018-021-02227-6.

Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy

Affiliations

Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy

Weiyang Zhong et al. J Orthop Surg Res. .

Abstract

Background: The rapid progressive cervical spondylotic myelopathy (rp-CSM) which had a course of CSM less than 1 month and suffered rapidly progressive neurological deterioration had few reports. Therefore, it is important for us to recognize the pathophysiology of CSM especially the rp-CSM. The study aimed to investigate the risk factors for rapidly progressive (rp) neurological deterioration in patients with cervical spondylotic myelopathy (CSM).

Methods: A total of 159 patients were reviewed and divided into an rp-CSM group and a chronic-CSM (c-CSM) group. Various clinical indexes, including age, sex, Japanese Orthopaedic Association (JOA) score, intramedullary MR T2-hyperintensity, congenital/degenerative spinal stenosis, and local type of ossification of the posterior longitudinal ligament (OPLL), were analyzed, and independent risk factors were investigated.

Results: Thirty-four of 159 patients (21.4%) were diagnosed with rp-CSM. All patients were followed up for a mean of 68.56 ± 14.00 months in the rp-CSM group and 62.66 ± 19.95 months in the c-CSM group. No significant difference was found in sex, mean age, smoking and drinking status, diabetes mellitus (DM), hypertension, surgery time, blood loss, JOA score, degenerative spinal stenosis, or OPLL (local). Univariate analyses demonstrated that rp-CSM patients tended to have MR T2-hyperintensity, longer hospital stay, shorter waiting time for surgery, more congenital spinal stenosis, and worse neurological function and to prefer more posterior surgeries than c-CSM patients. A multiple logistic regression analysis showed that congenital spinal stenosis and MR T2-hyperintensity were independently related to the presence of rp-CSM.

Conclusions: MR T2-hyperintensity and congenital spinal stenosis were risk factors for rp-CSM. Although neurological function deteriorates rapidly, early surgical decompression is recommended and can achieve good neurological recovery after surgery, indicating that rp-CSM could be a reversible condition.

Keywords: Cervical spondylotic myelopathy,; MR T2-hyperintensity; Risk factor,.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
A 66-year-old female patient presented with Brown-Sequard syndrome of the left limbs and trunk for 3 days and was diagnosed with rp-CSM. a, b MRI showed spinal compression and T2-hyperintensity at the C5/6 disk level with edema at the C4–5 and C5–6 levels, probably due to spinal cord ischemia. c The patient underwent laminectomy and fusion, and the large disk was removed. d Postoperative MRI showed that decompression was satisfactory and neurological symptoms improved significantly

Similar articles

Cited by

References

    1. Singh A, Tetreault L, Casey A, Laing R, Statham P, Fehlings MG. A summary of assessment tools for patients suffering from cervical spondylotic myelopathy: a systematic review on validity, reliability and responsiveness. Eur Spine J. 2015;24(suppl 2):209–228. doi: 10.1007/s00586-013-2935-x. - DOI - PubMed
    1. Wu JC, Ko CC, Yen YS, et al. Epidemiology of cervical spondylotic myelopathy and its risk of causing spinal cord injury: a national cohort study. Neurosurg Focus. 2013;35:E10. doi: 10.3171/2013.4.FOCUS13122. - DOI - PubMed
    1. Sadasivan KK, Reddy RP, Albright JA. The natural history of cervical spondylotic myelopathy. Yale J Biol Med. 1993;66:235–242. - PMC - PubMed
    1. Takasawa E, Sorimachi Y, Iizuka Y, et al. Risk factors for rapidly progressive neurological deterioration in cervical spondylotic myelopathy. Spine (Phila Pa 1976). 2019;44(12):E723–E730. doi: 10.1097/BRS.0000000000002969. - DOI - PubMed
    1. Morishita Y, Matsushita A, Maeda T, et al. Rapid progressive clinical deterioration of cervical spondylotic myelopathy. Spinal Cord. 2015;53(5):408–412. doi: 10.1038/sc.2014.137. - DOI - PubMed

Supplementary concepts

LinkOut - more resources